Leap Therapeutics, Inc. financial data

Symbol
LPTX on Nasdaq
Location
47 Thorndike Street, Suite B1 1, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 218 % -55.9%
Debt-to-equity 28.6 % +52%
Return On Equity -316 % -172%
Return On Assets -176 % -88.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 56.7M shares +47.8%
Common Stock, Shares, Outstanding 41.4M shares +8.3%
Entity Public Float 73.5M USD -5.41%
Common Stock, Value, Issued 41K USD +7.9%
Weighted Average Number of Shares Outstanding, Basic 41.4M shares +0.57%
Weighted Average Number of Shares Outstanding, Diluted 41.4M shares +0.57%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 37.8M USD -32.2%
General and Administrative Expense 9.76M USD -24.8%
Operating Income (Loss) -52.1M USD +24.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.1M USD +82.2%
Income Tax Expense (Benefit) 202K USD -71.5%
Net Income (Loss) Attributable to Parent -50.8M USD +21.3%
Earnings Per Share, Basic -1 USD/shares -50.6%
Earnings Per Share, Diluted -1 USD/shares -50.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.69M USD -84.6%
Assets, Current 10.5M USD -83.5%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 38K USD -89.7%
Other Assets, Noncurrent 15K USD -80%
Assets 11.4M USD -82.5%
Accounts Payable, Current 4.28M USD -28%
Employee-related Liabilities, Current 401K USD -85.2%
Accrued Liabilities, Current 3.86M USD -57.3%
Liabilities, Current 8.7M USD -45.9%
Operating Lease, Liability, Noncurrent 39K USD +2.63%
Liabilities 8.7M USD -45.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -104K USD -1833%
Retained Earnings (Accumulated Deficit) -503M USD -11.2%
Stockholders' Equity Attributable to Parent 2.7M USD -94.5%
Liabilities and Equity 11.4M USD -82.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.5M USD +6.68%
Net Cash Provided by (Used in) Financing Activities -61K USD
Common Stock, Shares Authorized 240M shares 0%
Common Stock, Shares, Issued 41.4M shares +8.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.5M USD +7.54%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.69M USD -84.6%
Deferred Tax Assets, Valuation Allowance 57.5M USD +50.5%
Deferred Tax Assets, Gross 57.5M USD +50.5%
Operating Lease, Liability 38K USD -89.9%
Depreciation 5K USD +25%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -50.9M USD +22.1%
Lessee, Operating Lease, Liability, to be Paid 38K USD -90.3%
Property, Plant and Equipment, Gross 226K USD 0%
Operating Lease, Liability, Current 38K USD -89.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 268K USD -40.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 38K USD -86.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2K USD -94.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 268K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 506M USD +0.93%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%